Loading...

Home
ETF
AMLX

AMLX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AMLX News

Joshua B Cohen Sells 138,167 Shares for $1.9 Million

Feb 01 2026NASDAQ.COM

Amylyx Pharmaceuticals CEO Executes Significant Stock Sale Amid Ongoing Investigation

Feb 01 2026Fool

Investigation into Amylyx Pharmaceuticals' Corporate Governance Breaches

Jan 29 2026PRnewswire

AMLX Options Contract Analysis and Investment Opportunities

Jan 27 2026NASDAQ.COM

Amylyx Pharmaceuticals (AMLX) Hits New 52-Week High with Over 50% Gain

Jan 22 2026NASDAQ.COM

AMLX Options Analysis: Put Contract Yield Boost of 6.15%

Jan 16 2026NASDAQ.COM

Amylyx Pharmaceuticals (AMLX) Hits Oversold RSI of 29.0 Amid Heavy Selling

Jan 05 2026NASDAQ.COM

Amylyx and MAIA Executives Increase Stock Holdings Amid Market Fluctuations

Dec 26 2025NASDAQ.COM

Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise

Dec 17 2025NASDAQ.COM

Amylyx Advances AMX0114 to Second Cohort Enrollment After Positive Phase 1 Results

Dec 05 2025Newsfilter

Halper Sadeh Investigates Amylyx Pharmaceuticals for Potential Fiduciary Breaches

Nov 29 2025PRnewswire

December 2026 Options for Amylyx Pharmaceuticals (AMLX) Now Accessible

Nov 07 2025NASDAQ.COM

Amylyx Pharmaceuticals Stock Declines Following Q3 Earnings Report

Nov 06 2025Yahoo Finance

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Avantor, Inc. (NYSE: AVTR), Humana Inc. (NYSE: HUM), and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office is Looking into Claims for You

Nov 06 2025Globenewswire

Crucial Update for Long-Term Investors in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office is Looking into Claims for You

Oct 30 2025Globenewswire

Reasons to Consider Buying Amylyx Pharmaceuticals, Inc. (AMLX) as a Strong Momentum Stock

Oct 24 2025NASDAQ.COM